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Objective: The purpose of this report is to discuss the incidence, diagnosis, and management of stent graft infections after
endovascular aneurysm repair (EVAR).
Methods: Data were collected from the hospital database and medical case notes for all patients with infected endografts
after elective or emergency EVAR for abdominal aortic aneurysm (AAA) during the last 8 years in two university teaching
hospitals in Northern Ireland. The data included the patient’s age, gender, presentation of sepsis, treatment offered, and
the ultimate outcome. The diagnosis of graft-related sepsis was established by a combination of investigations including
inflammatory markers, labelled white cell scan, computed tomography (CT) scan, microbiology cultures, and postmor-
tem examination.
Results: Graft-related septic complications occurred in six of 509 patients, including 433 elective repairs and 76
emergency endografts for ruptured AAA. Two patients presented with left psoas abscess and were treated successfully
with extra-anatomic bypass and removal of the infected stent graft. Two more patients presented with infected graft
without other evidence of intra-abdominal sepsis: one underwent successful removal of the infected prosthesis with
extra-anatomical bypass, and the other was treated conservatively and died of progressively worsening sepsis. The fifth
patient presented with unexplained fever and died suddenly, with a postmortem diagnosis of aortoenteric fistula and
ruptured aneurysm. The last patient presented with an aortoenteric fistula, was treated conservatively in view of
concurrent myelodysplasia, and died of possible aneurysm rupture.
Conclusion: This report emphasizes the need for continued awareness of potential graft-related septic complications in
patients undergoing EVAR of AAA. Attention to detail with regard to sterility and antibiotic prophylaxis during stent
grafting and during any secondary interventions is vital in reducing the risk of infection. In addition, early recognition
and prompt treatment are essential for a successful outcome. (J Vasc Surg 2007;46:442-8.)Prosthetic aortic graft infection after open repair of
abdominal aortic aneurysm (AAA) has been well reported
during the last 3 decades with a range of clinical manifes-
tations and therapeutic options,1 but infective complica-
tions involving endografts after endovascular aneurysm re-
pair (EVAR) have received little attention. Most EVAR
surveillance concentrates on the technical aspects of the
procedure, including endoleaks, device migration, neck
dilatation, and rupture.2-5 So far, there is limited knowl-
edge on infective complications after EVAR.
Since Chalmers et al6 described the first case of an
infected stent in 1993, more centers have reported graft-
related septic complications, usually in the form of single
case reports. A recent multicenter retrospective study of 65
patients with infected endografts7 failed to provide enough
data for statistical analysis. The purpose of this short series
is, therefore, to simply examine our experience of infective
complications after EVAR at two university centers rather
than define the broad principles in the management of
infected endovascular grafts.
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442PATIENTS AND METHODS
Data were collected from the hospital database for all
patients undergoing elective or emergency EVAR for AAA
during the last 8 years in the only two university teaching
hospitals undertaking endovascular stenting in Northern
Ireland, with a population of 1.7 million. Patients under-
going EVARwere followed up in the vascular clinics at 1, 3,
and 12months and at yearly interval thereafter, unless there
was a reason for earlier follow-up. At each visit, patients
underwent four views of plain abdominal radiographs (an-
teroposterior, lateral, right anterior oblique, and left ante-
rior oblique) to assess the mechanical integrity of the stent,
contrast-enhanced computed tomography (CT) scan, and a
blood test for levels of serum urea, creatinine, and electro-
lytes.
Those patients who were reviewed in the follow-up
clinic 15 months of the date of data collection were
considered to be compliant with the follow-up. If a patient
failed to attend follow-up, the general practitioner was
contacted. All deaths were identified through the hospital
system, the general practitioner, and the Registry Office for
Deaths in Northern Ireland. In addition, we were notified
of any patient who became unwell and was admitted to
another hospital for any reason.
In view of a closely linked community, all patients live
100-mile radius from the two hospitals performing
EVAR. Therefore, the follow-up arrangements are ade-
quate to identify any graft-related complications in a closely
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patients who presented with infective complications in this
series. The data collected for these patients included age,
gender, comorbidities, type of stent graft used, prophylac-
tic antibiotic regimen, adjuvant endovascular interventions,
presentation of sepsis, time interval between EVAR and
graft sepsis, treatment offered, and the ultimate outcome.
The diagnosis of graft-related sepsis was established by a
combination of investigations, including inflammatory
markers, labelled white cell scan, CT scan, microbiology
cultures, and postmortem examination.
Statistical analysis. Kaplan-Meier life-table analysis
was used for freedom from graft-related sepsis using SPSS
14.0.1 (SPSS Inc, Chicago, Ill) for Windows (Microsoft
Inc, Redmond, Wash). Patients were censored if they were
converted to open repair, underwent axillofemoral graft,
died during the course of follow-up, or failed to comply
with the follow-up protocol.
RESULTS
From November 1998 to January 2007, 509 patients
underwent EVAR for AAA, including 433 elective repairs
and 76 emergency endografts for ruptured AAA. During
this period, stent graft–related sepsis was encountered in six
patients, for a total follow-up duration of 968 person-years.
The incidence of graft-related sepsis was 6.2/1000 person-
years (6/968  1000). The average duration of follow-up
was 1.9 years (range, 0 to 8.2 years), with only 15.1%
(77/509) lost to follow-up (Table I). The cause of death in
patients undergoing elective and emergency EVAR is sum-
marized in Table II. Life-table analysis demonstrating free-
dom from graft-related sepsis is illustrated by Kaplan-Meier
curve (Fig 1). The outcomes of the six patients who pre-
sented with graft-related sepsis are summarized (Table III).
Patient 1. A 71-year-old man was admitted for elec-
tive repair of aortic and bilateral common iliac artery aneu-
rysms. The right internal iliac artery was already throm-
bosed, but the left was aneurysmal and patent. This vessel
was coil-embolized 3 days before EVAR. The stent graft
procedure was performed uneventfully using a Zenith aor-
tobiiliac stent (Cook Europe, Bjaeverskov, Denmark), and
a routine follow-up CT scan 1 month after the primary
Table I. Follow-up data for endovascular aneurysm
repair of 509 patients during an 8-year period
Patient category Patients, n (%)
Confirmed deaths 146 (28.7)
Continued follow-up* 275 (54)
Excluded from follow-up
Converted to open repair 6 (1.2)
Converted to axillofemoral bypass 2 (0.4)
Unwilling patient 2 (0.4)
Patient moved out of province 1 (0.2)
Lost to follow-up† 77 (15.1)
*Last clinic visit 15 months.
†Last clinic visit 15 months.repair was satisfactory.The patient was admitted 6 months later with left flank
and back pain, and a pyrexia of 38°C. The leukocyte count
was 9000/mm3, C-reactive protein (CRP) level was 191
mg/L, and the erythrocyte sedimentation rate (ESR) was
127.0 mm/h. Propionibacterium avidum was found on
blood culture, and a labelled white cell scan showed in-
creased uptake in relation to the distal part of themain body
of the stent graft (Fig 2). Intravenous piperacillin/tazobac-
tam was started based on sensitivities obtained from blood
cultures. A CT scan showed an area of low density in the left
psoas muscle with peripheral enhancement suggestive of an
acute abscess (Fig 3). Under CT guidance, 250 mL of pus
was aspirated from the abscess cavity and a drain was left in
situ. The culture of aspirated pus failed to show any growth,
however.
Bilateral axillofemoral bypasses were done before the
exposure of the aneurysm through a midline approach. A
suprarenal aortic clamp was applied before the pus-filled
aneurysm sac was opened (Fig 4). Because the stent graft
was barbed, the upper end was crimped down before it was
pulled down. The iliac limbs of the graft were well incor-
porated into the native vessel and were removed surgically.
Oversewing of aorta and both iliac arteries was done using
a single layer of nonabsorbable sutures, without the need
for double rows, which could weaken the aortic stump. A
drain was left in the aneurysm sac.
Culture of the stent graft and pus did not show any
growth. Intravenous antibiotics were continued until the
Table II. Cause of death in 146 endovascular aneurysm
repair patients during an 8-year period
Cause of death Patients, n
Elective EVAR repair 108
Cardiac 22
Malignancy 19
Multiple organ failure 14
Respiratory failure 12
Renal failure 7
Stroke 4
Bowel ischemia 3
Systemic sepsis 3
Ruptured AAA after EVAR 3
Endograft infection 2
Bleeding diverticular disease 1
No record available 18
Emergency EVAR for ruptured AAA 38
Multiple organ failure 12
Cardiac 7
Uncontrolled rupture 4
Coagulopathy 3
Acute renal failure 3
Respiratory tract infection 2
Stroke 2
Type III endoleak 1
Bowel ischemia 1
Malignancy 1
Endograft infection 1
No record available 1
EVAR, Endovascular aneurysm repair; AAA, abdominal aortic aneurysm.patient was discharged at 3 weeks, followed by a further
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inflammatory markers had returned to normal and a
follow-up CT scan was unremarkable. The antibiotics were
stopped at this stage.
Patient 2. A 75-year-old man underwent uneventful
endovascular repair of an inflammatory AAA using an aor-
tobiiliac Zenith stent graft. The follow-up CT scan at 4
months showed a small, well-circumscribed collection an-
terior to the left psoas muscle. This yielded thick pus at
aspiration, and despite aggressive antibiotic treatment with
intravenous piperacillin/tazobactam, it progressively en-
larged and extended to the left limb of the stent graft. At 12
months after primary repair, he became progressively more
septic with pyrexia, a leukocyte count of 18,800/mm3,
CRP level of 156.0 mg/L, and a blood culture showing
Streptococcus constellatus.
At surgery, a supraceliac aortic balloon was positioned
in the descending aorta through the transfemoral route.
Laparotomy revealed an inflammatory mass surrounding
the neck of the aneurysm. The supraceliac balloon was
inflated before the aneurysm sac was opened and the in-
fected graft was explanted. The aortic stump and both
common iliac arteries were oversewn. A further abscess was
located close to the left iliac limb of the graft extending over
the left psoas. The procedure was completed by an axillo-
bifemoral bypass after the abdomen was closed and re-
draped. In this particular case, the operating surgeon pre-
ferred to insert the axillofemoral graft after the removal of
the infected endograft to diminish bacteremia and prevent
Fig 1. Kaplan-Meier life table analysis demonstrates freedom
from graft-related sepsis. The number of patients at risk for each
interval time is shown.possible infection of the axillofemoral graft.The periendograft pus grew coliforms and streptococci,
and the patient was treated with intravenous piperacillin/
tazobactam for 3 weeks postoperatively, followed by a
further course of oral ciprofloxacillin. His postoperative
recovery was complicated by dialysis-dependent renal fail-
ure and atrial fibrillation requiring long-term anticoagula-
tion. His inflammatory markers returned to baseline at 9
months after graft removal (leukocytes 7000/mm3 and
CRP 7 mg/L) at which stage his antibiotics were
stopped. He remained on dialysis and died 4.5 years later
from amassive bowel hemorrhage secondary to diverticular
disease.
Patient 3. A 77-year-old man underwent elective
EVAR for a 6.8-cm AAA using an aortobiiliac Zenith stent
graft. Postoperatively, a type II endoleak from a lumbar
artery caused slow sac expansion. By 4 years after the
primary repair, the sac had expanded to 7.9 cm, and he
underwent unsuccessful ultrasound-guided percutaneous
thrombin injection into the sac in an attempt to seal the
leak. Nine months later, with continued expansion of the
sac to 8.1 cm, coil embolization was done for the persistent
type II endoleak. Both adjuvant procedures were done in
the interventional radiology suite without prophylactic an-
tibiotic cover.
The patient was readmitted 12 days after the coil em-
bolization with a 1-week history of backache and pyrexia.
The leukocyte count was 9500/mm3, CRP level was 305.3
mg/L, and the ESR was 127.0 mm/h. A CT scan demon-
strated soft-tissue thickening and air in the right anterolat-
eral aspect of the aneurysm sac suggestive of graft infection.
A blood culture grew coagulase negative Staphylococcus,
and he was started on intravenous piperacillin/tazobactam
and teicoplanin.
He underwent right axillobifemoral bypass and exci-
sion of the infected graft with oversewing of the aortic
stump and both common iliac arteries. Cultures of the pus
collected intraoperatively and the excised graft were nega-
tive, and intravenous antibiotics were continued for 2
weeks, followed by a further course of oral doxycycline and
rifampicin until his CRP level returned to base line. The
patient made a good recovery, and 12 months later, his CT
scan showed no evidence of residual sepsis, with a CRP level
of 14 mg/L and functioning axillofemoral bypass.
Patient 4. A 76-year-old man was admitted 12
months after a successful elective EVAR with a Talent
aortobiiliac device (Medtronic, Inc, Minneapolis, Minn).
He presented with lower abdominal pain, fever, leukocyto-
sis (24,000/mm3), and highCRP level (240mg/L). Three
consecutive blood cultures grew Staphylococcus aureus, and
a CT scan showed marked thickening of the aortic wall at
the neck of AAA, with adjacent lymphadenopathy and
stranding of the surrounding fat planes suggestive of in-
tense inflammatory response (Fig 5). He had an acute
coronary event during his hospital stay and was considered
unsuitable for graft removal in view of his deteriorating
general condition, impaired renal function, and poor car-
diac reserve. In view of his comorbidities, he was treated
with intravenous flucloxacillin and oral rifampicin based on
BG, coronary artery bypass grafting; COAD, chronic obstructive airway disease;
ccident; OR, operating room; IR, interventional radiology.
JOURNAL OF VASCULAR SURGERY
Volume 46, Number 3 Sharif et al 445the sensitivities from blood culture. Unfortunately, he died
from systemic sepsis and progressively deteriorating cardiac
function at 8 weeks from the diagnosis of his graft infection.
A postmortem examination confirmed an intact stent graft
without evidence of rupture and severe coronary artery
disease.
Patient 5. A 67-year-old man underwent successful
EVAR for a ruptured AAA using an aortouniiliac Talent
device, an occluder in the contralateral iliac artery, and a
femorofemoral bypass. Results of follow-up CT scans at 2
and 6 months were unremarkable. He was admitted 10
months after with profuse sweating, backache, and a feeling
of malaise. The patient’s hemodynamic parameters were
stable on admission, with hemoglobin level of 9.4 gm/dL,
leukocyte count of 16,800/mm3, CRP level of 185 mg/L,
and creatinine level of 269 mol/L. An urgent CT scan
was arranged, but before this could take place, the patient
Table III. Variables of patients with stent graft–related se
Variable Patient 1 Patient 2
Age at graft
infection
71 75
Gender Male Male M
Pre-existing risks Angina, NIDDM,
smoking
Angina, CABG,
COAD,
smoking,
hypertension
E
Immunodeficiency Nil Nil N
Urgency Elective Elective E
Device Aortobiiliac Aortobiiliac A
Manufacturer Zenith Zenith Z
Procedure setting OR OR O
Antibiotic
prophylaxis
Cefuroxime, 1.5 g Cefuroxime,
1.5 g
C
IV single dose Teicoplanin, 400
mg
—
Anesthesia General General G
Adjuvant
procedures
Coil embolization
of left IIA
Nil T
Presentation Left psoas abscess Left psoas
abscess
E
Interval between
EVAR sepsis
diagnosis
6 months 12 months 6
Microbiology
culture
Propionibacterium
avidum (blood)
Streptococcus
spp;
coliforms
(abscess)
S
Treatment EAB, removal of
infected graft
EAB, removal
of infected
graft
E
Outcome Survived Survived S
Duration of
follow-up from
graft removal to
date/death
3 months, alive 53 months,
died of
diverticular
bleeding
3
NIDDM, Noninsulin dependent diabetes; EAB, extra-anatomic bypass; CA
IIA, internal iliac artery; MI, myocardial infarction; CVA, cerebrovascular asuddenly collapsed with massive hematemesis. Resuscita-
Fig 2. Labelled white cell scan shows area of increased uptake inpsis after endovascular aneurysm repair
Patient 3 Patient 4 Patient 5 Patient 6
77 76 67 70
ale Male Male Male
x-smoking,
prostatism
NIDDM,
hypertension,
chronic renal
impairment
MI, CVA,
smoking,
hypertension,
COAD
CABG, Crohn
disease
il Nil Nil Myelodysplasia
lective Elective Emergency Elective
ortobiiliac Aortobiiliac Aortouniiliac Aortobiiliac
enith Talent Talent Zenith
R IR IR IR
efuroxime,
1.5 g
Cefuroxime,
1.5 g
Cefuroxime,
1.5 g
Cefuroxime,
1.5 g
— Teicoplanin,
400 mg
Teicoplanin,
400 mg
—
eneral General Local General
hrombin
injection,
coil
embolization
Nil Nil Nil
ndograft
infection
Endograft
infection
AEF AEF
1 months 12 months 10 months
(PM)
5 months
taphylococcus
epidermidis
(blood)
Staphylococcus
aureus
(blood)
Nil Nil
AB, removal
of infected
graft
Conservative Nil Conservative
urvived Died, systemic
sepsis (8 wks
postdiagnosis)
Died,
rupture
Died, possible
rupture
5 months,
alive
— — —the distal part of the stent graft (arrowhead).
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vealed aortic inflammation with adhesions and a fistulous
communication between the duodenum and anterior aortic
wall.
Patient 6. This last patient, a 70-year-old man with
a history of Crohn’s disease, has previously been report-
ed.8 He underwent endovascular repair using a bifur-
cated Zenith stent graft and presented 4 months later
with epigastric discomfort, fever, and melena. The pres-
ence of an aortoenteric fistula (AEF) was confirmed by
CT scan and a barium meal. He was treated conserva-
tively with intravenous antibiotics in view of his concur-
rent aggressive myelodysplastic condition and poor
prognosis. A repeat CT scan 8 months after the initial
repair showed complete destruction of the aneurysm sac.
Two months later, he suddenly collapsed and died in the
hospital. The family declined a request for postmortem
examination.
DISCUSSION
Conventional open repair of AAA has a reported graft
Fig 3. Computed tomography scan shows (arrowhead
large area of low density anterior to left psoas muscle
enhancement suggestive of acute abscess.infection rate of 0.5% to 3%.9 In this series, the incidence ofstent graft–related sepsis was 6.2/1000 person-years. Du-
casse et al7 reported a mean frequency of infection at 0.43%
based on 42 cases of infected endografts within an overall
experience of 9739 endovascular procedures. This fre-
quency does not represent the true incidence of stent graft
infections, however, because information on completeness
of follow-up and deaths is not included. Nevertheless, the
Ducasse series includes a much larger database from multi-
ple centers than our report and thus might be a more
reliable source for patient-based incidence of EVAR infec-
tion.
So far, the association between adjuvant endovascular
procedures and the risk of stent graft infection is unclear.
Two patients in this series underwent an associated endolu-
minal procedure. The coil embolization of the left internal
iliac artery aneurysm was done 3 days before EVAR in
patient 1, and a left psoas abscess and graft infection later
developed. In this case, it is difficult to ascertain whether
the coil embolization was responsible for the subsequent
events. However, coil embolization for type II endoleak in
left limb of the aortobiiliac device and (arrowhead b) a
adjacent to the left limb of the graft with peripherala) the
andpatient 3 was clearly followed by a rapid onset of graft sepsis
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evidence of graft infection for 5 years.
It was interesting to note that graft sepsis was associated
with AEF in two patients. Anecdotally, we thought that the
excessive anterior neck angulation in patient 5, with possi-
ble extra pressure on the duodenum, could have contrib-
uted towards the fistulization; however, the Talent stent
graft used had no intramural barbs. Although the suprare-
nal component of the Zenith stent graft has barbs, it is
unlikely that it contributed to the formation of an AEF in
patient 6. The AEF is more likely to be related to the
Fig 4. Intraoperative picture shows (arrowhead a) aneurysm sac
opened up with pus aspirated from the sac, (arrowhead b) stent
graft inside the sac, and (arrowhead c) a back-bleeding lumbar
artery controlled with a suture.
Fig 5. Computed tomography scan shows (arrowhead a)marked
thickening of the aortic wall, (arrowhead b) adjacent lymphade-
nopathy, and (arrowhead c) stranding of the surrounding fat planes
suggestive of intense inflammatory response.presence of small bowel Crohn’s disease. These interpreta-tions are unsupported speculations, however, and it is still
most likely that a primary stent graft infection led eventually
to erosion of an adherent segment of bowel. Other causes
of AEF in association with the aortic stent graft described in
recent literature include stent migration,10,11 erosion of the
aorta and duodenum by embolization coils,12,13 fabric
rupture,14 inflammatory nature of the aneurysm,15 and
bacterial aortitis with chronic duodenal erosion.16
Reports have shown that patients with infected stent
grafts who are managed conservatively with antimicrobial
therapy and percutaneous drainage can still survive.7 In this
series, however, two of the three patients without surgical
treatment died of ruptured aneurysm. In patient 5, the
death was sudden, and treatment options could not be
exercised; in fact, the diagnosis of AEFwas onlymade at the
postmortem examination. The third patient treated conser-
vatively died of progressive sepsis and cardiac failure. Al-
though conservative treatment of high-risk patients has
been proposed by some authors, most would agree that the
infected stent graft should be removed if the patient’s
condition permits.17
The three patients in the current series who underwent
removal of the infected prosthesis and axillobifemoral by-
pass survived. Ducasse et al7 reported 16% mortality with
extra-anatomic bypass in this situation. Although the three
patients undergoing graft removal in our series had extra-
anatomic reconstruction, recent studies have questioned
the choice of this approach.
The duration of the antimicrobial treatment in patients
undergoing removal of the infected prosthesis in this series
was guided by serial estimation of CRP level. Because no
current guidelines exist on the exact duration of treatment
in this situation, our regimen was based on expert consen-
sus involving local microbiologist, vascular surgeons, and
the interventional vascular radiologists. Another change in
our protocol for antibiotic prophylaxis was made after the
finding of graft-related sepsis in patient 3, where thrombin
injection without antibiotic cover was followed a week later
by graft infection. We now routinely cover all secondary
interventions in EVAR patients by a single intravenous dose
of teicoplanin and cefuroxime.
Our case series has two main limitations. First, the
number of infected patients still remains very small, but
endograft-related sepsis is an uncommon event. In view of
the small numbers, the contribution of different risk factors
toward the etiology of graft infection is difficult to evaluate.
As the duration of follow-up increases beyond the first
decade, more cases may come to light. Second, this series is
insufficient to provide a comparative data set to allow
assessment of the effectiveness of different treatment mo-
dalities in endograft infections.
CONCLUSION
The incidence of stent graft–related sepsis is currently
low. Nevertheless, as more patients are treated by endovas-
cular technique, there is an increasing need to be vigilant
for the risk of graft infection. Better appreciation of the
potential risk of stent graft infection and an obsession to
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with timely use of appropriate antibiotic regimens during
primary and secondary interventions, may help to minimize
the risk of graft-infection. A high index of suspicion is also
required for diagnosis because the clinical presentation
could be varied. Removal of the infected prosthesis and
restoration of the blood flow to the lower extremities is
recommended when possible.
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